AtaiBeckley (ATAI) Net Cash Flow (2020 - 2026)
AtaiBeckley (ATAI) posted Net Cash Flow of -$31.1 million for Q3 2025, down 1001.36% sequentially from $3.4 million in Q2 2025, and down 398.95% YoY from $10.4 million in Q3 2024.
Analysis
AtaiBeckley (ATAI) Net Cash Flow (2020 - 2026) Analysis & Trends
AtaiBeckley's Net Cash Flow history runs 2 years deep, the most recent figure standing at -$41.9 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 236.33% year-over-year to -$41.9 million; the TTM figure through Mar 2026 stood at -$11.2 million (changed N/A YoY), while the FY2025 annual figure was $57.7 million, up 422.39% from the prior year.
- Net Cash Flow slipped to -$31.1 million in Q3 2025 per ATAI's latest filing, from $3.4 million in the prior quarter.
- The five-year high for Net Cash Flow was $30.8 million in Q1 2025, with the low at -$41.9 million in Q1 2026.
- A 5-year average of -$3.5 million and a median of -$11.1 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow sank 987.68% in 2022, then soared 763.91% in 2025.
- Over 5 years, Net Cash Flow stood at -$67.4 million in 2021, then jumped by 172.12% to $48.6 million in 2022, then plunged by 164.26% to -$31.2 million in 2023, then surged by 43.73% to -$17.6 million in 2024, then tumbled by 76.72% to -$31.1 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$31.1 million, $3.4 million, and $30.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | -31.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.95 Mn |
| Mar 31, 2026 | -41.92 Mn |
| Sep 30, 2025 | -31.07 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 3.45 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Mar 31, 2025 | 30.75 Mn |
| Dec 31, 2024 | -17.58 Mn |
| Sep 30, 2024 | 10.39 Mn |
| Jun 30, 2024 | 399,000.00 |
| Mar 31, 2024 | -11.10 Mn |
| Dec 31, 2023 | -31.25 Mn |
| Sep 30, 2023 | -64.92 Mn |
| Jun 30, 2023 | -44.72 Mn |
| Mar 31, 2023 | -4.89 Mn |
| Dec 31, 2022 | 48.63 Mn |
| Sep 30, 2022 | 57.79 Mn |
| Jun 30, 2022 | -38.35 Mn |
| Mar 31, 2022 | -238.59 Mn |
| Dec 31, 2021 | -67.42 Mn |